Laval Factsheet
Laval is the mothership site of Nexelis, a Q2 Solutions Company, with a history of success in developing vaccine technology for a broad array of infectious diseases.
Download our factsheet to learn more.
Laval is the mothership site of Nexelis, a Q2 Solutions Company, with a history of success in developing vaccine technology for a broad array of infectious diseases.
Download our factsheet to learn more.
Q2 Solutions has the scientific and technical expertise to support you in vaccine immunogenicity testing.Download our factsheet to learn more.
We are Q2 Solutions, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. Launched...
This presentation highlights the challenges of emerging and re-emerging infectious diseases such as MTB, HIV, MRSA, and Ebola.This presentation also provides case studies on how innovative...